Abstract | PURPOSE: EXPERIMENTAL DESIGN: plasmas from CDG-negative, COG-CDG, and ATP6V0A2-CDG patients were analyzed and results were compared to those obtained using 2DE followed by Western blot. RESULTS: MALDI-TOF of apoC-III allowed to detect various significant O- glycan abnormalities in CDG-patients with emphasis to COG-CDG. Furthermore, in CDG samples, comparison study between 2DE and MALDI-TOF showed a particular behavior of monosialylated apoC-III in the mass spectrometer that could be related to an abnormal O- glycan structure. CONCLUSIONS AND CLINICAL RELEVANCE: MALDI-TOF MS appears as a powerful technique for the analysis of apoC-III glycoforms for potential routine screening of COG- and ATP6V0A2-CDGs.
|
Authors | Stéphanie Yen-Nicolaÿ, Céline Boursier, Marlène Rio, Dirk J Lefeber, Antoine Pilon, Nathalie Seta, Arnaud Bruneel |
Journal | Proteomics. Clinical applications
(Proteomics Clin Appl)
Vol. 9
Issue 7-8
Pg. 787-93
(Aug 2015)
ISSN: 1862-8354 [Electronic] Germany |
PMID | 25641685
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- Apolipoprotein C-III
- Glycoproteins
- Mucins
- Polysaccharides
|
Topics |
- Apolipoprotein C-III
(metabolism)
- Blotting, Western
- Congenital Disorders of Glycosylation
(metabolism)
- Electrophoresis, Gel, Two-Dimensional
(methods)
- Glycoproteins
(metabolism)
- Humans
- Mucins
(chemistry, metabolism)
- Polysaccharides
(chemistry, metabolism)
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
(methods)
|